Diabetes
A short sentence to introduce what to expect in the about condition
section
Learn more
Check your eligibility now & get in touch with a study center
CHECK ELIGIBILITY
Drip Trial : Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant Therapy
Breast cancer has become the world's number one cancer. While its therapeutic efficacy is increasing, how to achieve non-invasive evaluation of the efficacy of neoadjuvant therapy (NAT) for breast cancer patients and thus avoid surgery has become a bottleneck problem that needs to be broken through in clinical diagnosis and treatment. Existing non-invasive evaluation strategies are limited to single-center, single-modality modeling, and have problems such as low performance and poor versatility. Therefore, in the early stage of this study, multi-modality breast cancer patient data from multiple centers across the country were collected and the establishment of an artificial intelligence (AI) efficacy prediction model was preliminarily completed. On this basis, this project intends to further improve the multi-center prospective validation study of the prediction model. The research results will help solve the scientific problem of non-invasive judgment of NAT efficacy in breast cancer patients and provide a new paradigm for the research of high-performance AI diagnosis and treatment auxiliary systems applicable to multiple centers.
Highlighted Text Block
You can use content blocks to arrange your articles, large texts,
instructions. Combine these blocks with media blocks to add
illustrations and video tutorials. You can use various content blocks to
work with your text. Add quotations, lists, buttons. Select your text to
change its formatting or add links. You can use various content blocks
to work with your text. Add quotations, lists, buttons. Select your text
to change its formatting or add links.
Diabetes
What is Diabetes?
A large percentage of viewers are on mobile devices, so keep it short
and to the point. Have you ever noticed how long a 5 sentence
paragraph looks on a smart phone? If you read it via desktop/laptop,
you realize it is really not that much information. A suggestion is to
plan on “marrying” the two and keep the chatter down. Conversely,
don’t sacrifice the “meat and potatoes” of what you’re trying to
convey; this will help to keep the organic SEO strong.
What causes Diabetes?
Viewers need to be given a direction every now and then. Use your
headers to draw the eye where you want it. Imagine the website as a
term paper and your outline will guide your structure. Focus broad
topics on the main headers and help guide the viewer down the right
path! Appropriately introducing call-to-action buttons also helps with
guiding the reader and connecting content writing with your website’s
goal.
How is Diabetes treated?
Here are a few website content writing tips to make sure your website
content gets the attention it deserves • Know your audience • Write
short, simple sentences – Nix the jargon – Mix up your word choice •
Make text scannable • Incorporate multimedia Capturing reader’s
interests with good website content and information can be
challenging. Most visitors will spend just a few seconds on a webpage,
before deciding what to do next. Therefore, good website writing is
the key to beating these odds.
More information about Diabetes
National Diabetes Foundation National Diabetes Foundation – Support
Network American Academy of Diabetes International Diabetes Council
International Federation of Diabetes Associations
Call 1800-9860-568 now to find out if you are eligible.
Are you a patient with moderate to severe plaque psoriasis?
Have you treated your condition with adalimumab (Humira®) and did it
become less effective on your plaque psoriasis within the last 6 months?
If so, you may be eligible for a clinical research study with etanercept
(Enbrel®) which is also approved for moderate to severe plaque
psoriasis. Qualified participants will receive an initial consultation,
study-related examinations, and study medication.
Are you a patient with moderate to severe plaque psoriasis?
Have you treated your condition with adalimumab (Humira®) and did it
become less effective on your plaque psoriasis within the last 6 months?
If so, you may be eligible for a clinical research study with etanercept
(Enbrel®) which is also approved for moderate to severe plaque
psoriasis. Qualified participants will receive an initial consultation,
study-related examinations, and study medication.
The Study
A short sentence to introduce what to expect in the about condition
section
Learn more
About Clinical Trials
A short sentence to introduce what to expect in the about condition
section
Learn moreAre you a patient with moderate to severe plaque psoriasis?
Have you treated your condition with adalimumab (Humira®) and did it
become less effective on your plaque psoriasis within the last 6 months?
If so, you may be eligible for a clinical research study with etanercept
(Enbrel®) which is also approved for moderate to severe plaque
psoriasis. Qualified participants will receive an initial consultation,
study-related examinations, and study medication.
Are you a patient with moderate to severe plaque psoriasis?
Have you treated your condition with adalimumab (Humira®) and did it
become less effective on your plaque psoriasis within the last 6 months?
If so, you may be eligible for a clinical research study with etanercept
(Enbrel®) which is also approved for moderate to severe plaque
psoriasis. Qualified participants will receive an initial consultation,
study-related examinations, and study medication.
Check your eligibility
Take up this questionnaire to help us determine if you have symptoms
that are common to this clinical study. If you have the common
symptoms, you may be eligible to take part in the study.
Check if you are eligible
Enter contact info
We need your contact info for the study team to get in touch with you
Check if you are eligible
Choose from available locations
Create an alert
Would you like us to notify you if new site gets added near your preferred location?
Check if you are eligible
Check if you are eligible
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
Message sent successfully.
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Submitted
We have recorded your responses successfully. You will be notified when a new site matching your preferred location is added to the system.
We have recorded your responses successfully. You will not be notified when a new site matching your preferred location is added to the system.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Check if you are eligible
Your information has been sent successfully. A study member will get in touch with you soon.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Preview complete
The prescreener preview is complete. You may now close the preview.